TREM2 and skin basal cell carcinoma: The addition of anti-TREM2 antibodies caused a dramatic increase percentage of Apotracker Green epithelial cells in three of the four tumors, suggesting that targeting SCAMs in human BCC samples reduces epithelial cell viability (Fig. 6n, o and Supplementary Fig. 5e).